Apogee Therapeutics
The Executive Director of GMP Quality Assurance at Apogee Therapeutics leads the global GMP QA strategy during the transition from clinical development to commercial readiness. This role ensures compliance with regulations, builds a high-performing QA team, and oversees quality systems across internal and external partners.
Headquarters
San Francisco, California, United States
Company Size
51-200 employees
Founded
2022
Apogee Therapeutics is a clinical-stage biotechnology company developing differentiated biologics for immunological and inflammatory diseases. The company focuses on high-unmet-need conditions including atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other I&I disorders. Apogee advances therapeutic candidates through clinical development with the goal of delivering best‑in‑class treatments for patients with inflammatory and immune-mediated diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Apogee Therapeutics.
67% above the average for this role
A Look At Apogee Therapeutics (APGE) Valuation After Wider Losses And A New Shelf Registration
2 days ago
Senior Director, Global GMP Quality Assurance
Structure Therapeutics
Director, GMP Quality Assurance Operations
Mirum Pharmaceuticals
Head of Quality Assurance (QA)
GenScript
Director, Quality Assurance & Quality Systems
Capricor Therapeutics
Manager of Quality Assurance Product Complaints
Akero Therapeutics
Manager, Quality Assurance
Tango Therapeutics